2021-11-05T00:32:39-05:00 2020-12-31 861065772 DELOITTE TAX LLP 50 SOUTH SIXTH STREET MINNEAPOLIS MN 55402 990 2020-01-01 473290897 GATES PHILANTHROPY PARTNERS GATE 2067093100 PO BOX 23350 SEATTLE WA 98102 ROBERT ROSEN EXECUTIVE DIRECTOR 2067093100 2021-11-04 1 ROBERT ROSEN XXX-XX-XXXX ANNE FULTON P00941863 6123974000 3 AAL1 IAL1 2020 2022-09-23 18:48:47Z ROBERT ROSEN PO BOX 23350 SEATTLE WA 98102 173130385 0 X WWW.GATESFOUNDATION.ORG/PHILANTHROPYPARTNERS X 2015 WA GRANTMAKING & CHARITABLE ACTIVITIES TO PROMOTE GLOBAL DEVELOPMENT, GLOBAL HEALTH & EDUCATION 3 0 0 0 0 0 19430743 173118845 0 0 72630 11540 0 0 19503373 173130385 23920325 98941913 0 0 0 0 0 0 0 606417 596077 24526742 99537990 -5023369 73592395 4006202 91968050 2269090 16638543 1737112 75329507 X THE MISSION OF GATES PHILANTHROPY PARTNERS IS TO WORK IN PARTNERSHIP WITH THE BILL & MELINDA GATES FOUNDATION AND OTHER PHILANTHROPISTS TO PROMOTE GLOBAL DEVELOPMENT, GLOBAL HEALTH, AND U.S. EDUCATION THROUGH GRANTMAKING AND THE DIRECT CONDUCT OF CHARITABLE ACTIVITIES. 0 0 66781859 66781859 COMBATING COVID-19: CONTROLLING COVID-19 MEANS GETTING VACCINES TO EVERYONE, EVERYWHERE, WHILE MEETING BASIC HUMAN NEEDS LIKE ACCESS TO MEDICAL OXYGEN AND EXPEDITING INNOVATIONS IN TESTING AND TREATMENT. IN 2020, GATES PHILANTHROPY PARTNERS RECEIVED MORE THAN $100 MILLION FROM DONORS FOR ITS COMBATING COVID-19 FUND. FUNDING WAS DIRECTED TO OVER 25 GRANTEE PARTNERS ON THE FRONT LINES - TRAINING HEALTH WORKERS, PROVIDING COMMUNITIES WITH ACCESS TO CARE, AND SUPPORTING EDUCATORS. GRANTEES ARE ALSO WORKING BEHIND THE SCENES RESEARCHING THE VIRUS AND DISEASE, AND DEVELOPING TESTS, TREATMENTS, AND VACCINES. 31120053 31120053 GLOBAL HEALTH INNOVATION: AT OUR CORE, OUR WORK IS ABOUT TACKLING PREVENTABLE DISEASES THAT IMPERIL THE LIVES OF PEOPLE IN THE POOREST PARTS OF THE WORLD. OUR GRANTS IN GLOBAL HEALTH INNOVATION ACCELERATE SCIENCE - THE DISCOVERY, DEVELOPMENT, AND DELIVERY OF VACCINES, DRUGS, AND DIAGNOSTICS - TO PREVENT AND TREAT NEGLECTED DISEASES AND SAVE LIVES. 1040000 1040000 EMPOWERMENT & OPPORTUNITY: INVESTING IN WOMEN AND GIRLS HAS BEEN PROVEN TO REDUCE POVERTY, YET TOO MANY GIRLS AND WOMEN ARE DENIED AN EQUAL CHANCE TO LEARN, LEAD, EARN, AND THRIVE. WE MAKE GRANTS IN SEVERAL AREAS TO ADDRESS THESE ISSUES. FIRST, WE GRANT TO WOMEN'S COLLECTIVES, WHICH LIFT UP COMMUNITIES OF WOMEN TO BUILD SOLIDARITY, DEVELOP SUPPORT NETWORKS, POOL SAVINGS, AND SHARE FINANCIAL RISKS. SECOND, WE GRANT TO WOMEN IN LEADERSHIP TO ENCOURAGE AND CHAMPION WOMEN LEADERS IN KEY FIELDS. THIRD, OUR GRANTS IN WOMEN'S ECONOMIC EMPOWERMENT PUT FINANCIAL TOOLS IN WOMEN'S HANDS TO IMPROVE THEIR LIVES AND THEIR FUTURE. LAST, WE MAKE GRANTS IN FAMILY PLANNING TO INCREASE ACCESS FOR WOMEN AND ADOLESCENTS. 489407 GATES PHILANTHROPY PARTNERS (GPP) LEVERAGES THE DEEP PROGRAMMATIC EXPERTISE AND ADMINISTRATIVE INFRASTRUCTURE OF ITS SOLE MEMBER, BILL & MELINDA GATES FOUNDATION (BMGF) TO DEPLOY DONOR CONTRIBUTIONS TO SUPPORT STRONG, EXISTING BMGF-FUNDED PROJECTS WHERE ADDITIONAL FUNDS CAN ACHIEVE IMMEDIATE IMPACT. GPP PROJECTS FOCUS ON CORE THEMES OF BMGF, SUCH AS ELIMINATING DISEASES, CUTTING CHILDHOOD DEATHS IN HALF, ACCELERATING PROGRESS FOR WOMEN AND GIRLS, AND FURTHERING INNOVATION IN US EDUCATION. BY LEVERAGING BMGF'S PROGRAM AND FINANCIAL EXPERTISE, GPP CAN EVALUATE PROJECT OUTCOMES, ANALYZE IMPACT, AND MEASURE PROGRESS IN AN EFFORT TO END INEQUITY AND IMPROVE THE LIVES OF THE WORLD'S POOREST PEOPLE. GPP'S APPROACH TO GRANTMAKING EMPHASIZES COLLABORATION, INNOVATION, EVALUATION, AND, MOST IMPORTANTLY, RESULTS. 489407 99431319 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 3 0 1 0 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 0 0 0 AL AR CA CO FL GA HI IL KS KY MA MD MI MN MS NC NH NJ NM NY OH OR PA RI SC TN UT VA WA WI WV X X JENNIFER DEGER 2067093100 500 FIFTH AVENUE NORTH SEATTLE WA 98109 MARK SUZMAN DIRECTOR (END 8/12/2020) 1.00 40.00 X 0 1215075 81923 CONNIE COLLINGSWORTH DIRECTOR & BOARD CHAIR 1.00 40.00 X X 0 950900 70582 ALLAN GOLSTON DIRECTOR (START 8/12/2020) 1.00 40.00 X 0 835197 70582 LISA JOHNSEN DIRECT. & SEC. (START 3/18/20) 1.00 40.00 X X 0 450104 68916 SUSAN DESMOND-HELLMANN DIRECTOR (END 1/31/2020) 1.00 42.00 X 0 339358 39651 ROBERT ROSEN EXECUTIVE DIRECTOR 3.00 40.00 X 0 359930 79942 JONATHAN CASTRODALE TREASURER (START 11/2/2020) 1.00 40.00 X 0 313392 79680 GREG FERRANTE TREASURER (END 3/27/2020) 1.00 40.00 X 0 95763 27435 0 4559719 518711 0 0 1 0 PILOT LAB LLC 1201 10TH AVE SUITE C SEATTLE WA 98122 CONTENT AND CREATIVE SERVICES 307019 1 534066 172584779 173118845 11540 11540 173130385 0 0 11540 X 30173004 30173004 68768909 68768909 12379 12379 19401 19401 564236 489406 74830 5 5 DUES AND FEES 56 56 99537990 99431319 106671 0 2378976 81191317 1627226 10776733 4006202 91968050 3100 0 2265990 16638543 2269090 16638543 X -1438596 -11253034 3175708 86582541 1737112 75329507 4006202 91968050 73592395 0 X 0 1 X 1 0 X 3588650 4469535 23424174 19430743 173132419 224045521 3588650 4469535 23424174 19430743 173132419 224045521 107171096 116874425 0 3550 109919 72630 11540 197639 224243160 0.52120 0.70600 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 99537990 99537990 1000000 250000 0 0 204316 1000000 1000000 1000000 3204316 4806474 51079 250000 250000 250000 801079 1201619 1 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANT-MAKING GRANTMAKING 16436932 EAST ASIA AND THE PACIFIC 0 0 GRANT-MAKING GRANTMAKING 30000000 SUB-SAHARAN AFRICA 0 0 GRANT-MAKING GRANTMAKING 19375000 NORTH AMERICA 0 0 GRANT-MAKING GRANTMAKING 2606977 SOUTH ASIA 0 0 GRANT-MAKING GRANTMAKING 350000 0 0 0 0 0 0 68768909 0 68768909 SUB-SAHARAN AFRICA COVID-19 RESPONSE 9000000 ELECTRONIC FUND/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WOMEN EMPOWERMENT 1000000 ELECTRONIC FUND/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) COVID-19 RESPONSE 1199910 ELECTRONIC FUND/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) SUPPORT INNOVATIVE DIAGNOSTICS TECHNOLOGY 1600000 ELECTRONIC FUND/WIRE TRANSFER 0 SUB-SAHARAN AFRICA COVID-19 RESPONSE 1000000 ELECTRONIC FUND/WIRE TRANSFER 0 NORTH AMERICA COVID-19 RESPONSE 1989053 ELECTRONIC FUND/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) COVID-19 RESPONSE 1410492 ELECTRONIC FUND/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) COVID-19 RESPONSE 123000 ELECTRONIC FUND/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) COVID-19 RESPONSE 249000 ELECTRONIC FUND/WIRE TRANSFER 0 SUB-SAHARAN AFRICA COVID-19 RESPONSE 4425000 ELECTRONIC FUND/WIRE TRANSFER 0 SUB-SAHARAN AFRICA COVID-19 RESPONSE 600000 ELECTRONIC FUND/WIRE TRANSFER 0 SUB-SAHARAN AFRICA COVID-19 RESPONSE 600000 ELECTRONIC FUND/WIRE TRANSFER 0 SUB-SAHARAN AFRICA COVID-19 RESPONSE 1300000 ELECTRONIC FUND/WIRE TRANSFER 0 NORTH AMERICA COVID-19 RESPONSE 617924 ELECTRONIC FUND/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) COVID-19 RESPONSE 344805 ELECTRONIC FUND/WIRE TRANSFER 0 SOUTH ASIA COVID-19 RESPONSE 350000 ELECTRONIC FUND/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) COVID-19 RESPONSE 1500000 ELECTRONIC FUND/WIRE TRANSFER 0 SUB-SAHARAN AFRICA COVID-19 RESPONSE 700000 ELECTRONIC FUND/WIRE TRANSFER 0 SUB-SAHARAN AFRICA COVID-19 RESPONSE 750000 ELECTRONIC FUND/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) COVID-19 RESPONSE 10000000 ELECTRONIC FUND/WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC PUBLIC HEALTH 15000000 ELECTRONIC FUND/WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC PUBLIC HEALTH 15000000 ELECTRONIC FUND/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) VACCINE DEVELOPMENT 6087 ELECTRONIC FUND/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) VACCINE DEVELOPMENT 3637 ELECTRONIC FUND/WIRE TRANSFER 0 15 9 1 0 0 0 0 0 PART I, LINE 2: GATES PHILANTHROPY PARTNERS LEVERAGES THE PROCESS AND EXPERTISE OF BILL & MELINDA GATES FOUNDATION FOR SOLICITING AND REVIEWING GRANT PROPOSALS. BEFORE ANY GRANTS ARE MADE, GATES PHILANTHROPY PARTNERS MAKES INQUIRIES ABOUT THE PURPOSE AND ACTIVITIES OF THE RECIPIENT ORGANIZATION TO EVALUATE THE GRANTEE'S PLANNED USES, PROGRAMS, FINANCIAL SYSTEMS, AND LEADERSHIP. IN SOME INSTANCES, SITE VISITS ARE CONDUCTED AS WELL. GRANTEES SIGN WRITTEN AGREEMENTS THAT SPECIFY THE GRANT PURPOSE, TIMING OF PERIODIC REPORTS, AND REQUIRE A FINAL WRITTEN REPORTING AND ACCOUNTING FOR HOW THE GRANT FUNDS WERE SPENT. GATES PHILANTHOPY PARTNERS HAS THE AUTHORITY TO WITHHOLD AND/OR RECOVER ANY GRANT FUNDS THAT ARE, OR APPEAR TO BE, MISUSED. FROM TIME TO TIME, SPOT AUDITS ARE CONDUCTED ON SELECTED GRANTEES TO MONITOR WHETHER THE GRANTEES ARE COMPLYING WITH THE TERMS OF THEIR GRANT AGREEMENTS. ADDITIONALLY, OUTSIDE EXPERTS ARE PERIODICALLY ENGAGED TO PERFORM EVALUATION OF SELECTED GRANTEES TO ENSURE THE FUNDS ARE BEING USED FOR THE PURPOSES OF THE GRANT. PART I, LINE 3: GRANTS ARE REPORTED ON THE ACCRUAL BASIS OF ACCOUNTING. PART III ACCOUNTING METHOD: PART II, LINE 1(A): MULTIPLE GRANTS BENEFITTED MORE THAN ONE REGION AROUND THE WORLD. FOR PURPOSES OF 990 REPORTING, THE REGION LISTED IS THE REGION THAT RECEIVED A MAJORITY OF THE BENEFIT. THESE GRANTS ARE EXPECTED TO HAVE A GLOBAL IMPACT IN FUTURE YEARS. PART II, LINE 1: GRANTS ARE REPORTED ON THE ACCRUAL BASIS OF ACCOUNTING. 1 BILL & MELINDA GATES MEDICAL RESEARCH INSTITUTE ONE KENDALL SQUARE BUILDING 600 SUITE 6-301 CAMBRIDGE MA 02139 821808476 501(C)(3) 18000000 0 COVID-19 THERAPEUTICS CENTIVAX INC 201 GATEWAY BLVD FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 843193481 374906 0 VACCINE DEVELOPMENT CERTARA USA INC 100 OVERLOOK CENTER SUITE 100 PRINCETON NJ 08540 510625438 4172000 0 COVID-19 RESPONSE CORNELL UNIVERSITY 1300 YORK AVENUE BOX 89 NEW YORK NY 10065 150532082 501(C)(3) 490000 0 COVID-19 RESPONSE DIAGNOSTIC CONSULTING NETWORK INC 6354 CORTE DEL ABETO SUITE B CARLSBAD CA 92011 205531959 900000 0 COVID-19 RESPONSE DISTRIBUTED BIO INC 201 GATEWAY BLVD FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 462029273 619969 0 VACCINE DEVELOPMENT ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI ONE GUSTAVE L LEVY PLACE DEPT MICROBIOLOGY BOX 1124 NEW YORK NY 10029 136171197 501(C)(3) 100000 0 COVID-19 RESPONSE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE DEPARTMENT OF PEDIATRICS 200 N WOLFE STREET HARRIENT LANE ROOM 314 BALTIMORE MD 21287 520595110 501(C)(3) 1780639 0 COVID-19 RESPONSE PRESIDENT AND FELLOWS OF HARVARD COLLEGE 50 CHURCH STREET 4TH FLOOR CAMBRIDGE MA 22903 042103580 501(C)(3) 115454 0 VACCINE DEVELOPMENT SOMALOGIC INC 2945 WILDERNESS PLACE BOULDER CO 80301 522195896 490100 0 COVID-19 RESPONSE SOMALOGIC INC 2945 WILDERNESS PLACE BOULDER CO 80301 522195896 499937 0 COVID-19 RESPONSE TEMPLE UNIVERSITY -- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 1801 NORTH BROAD STREET PHILADELPHIA PA 19122 231365971 501(C)(3) 600000 0 COVID-19 RESPONSE THE SCRIPPS RESEARCH INSTITUTE 11119 NORTH TORREY PINES ROAD SUITE 100 LA JOLLA CA 92037 330435954 501(C)(3) 1989999 0 COVID-19 RESPONSE UNITED NATIONS FOUNDATION INC 1750 PENNSYLVANIA AVE NWSUITE 300 WASHINGTON DC 20006 582368165 501(C)(3) 40000 0 GENERAL OPERATING SUPPORT 8 6 PART I, LINE 2: GATES PHILANTHROPY PARTNERS LEVERAGES THE PROCESS AND EXPERTISE OF BILL & MELINDA GATES FOUNDATION FOR SOLICITING AND REVIEWING GRANT PROPOSALS. BEFORE ANY GRANTS ARE MADE, GATES PHILANTHROPY PARTNERS MAKES INQUIRIES ABOUT THE PURPOSE AND ACTIVITIES OF THE RECIPIENT ORGANIZATION TO EVALUATE THE GRANTEE'S PLANNED USES, PROGRAMS, FINANCIAL SYSTEMS, AND LEADERSHIP. IN SOME INSTANCES, SITE VISITS ARE CONDUCTED AS WELL. GRANTEES SIGN WRITTEN AGREEMENTS THAT SPECIFY THE GRANT PURPOSE, TIMING OF PERIODIC REPORTS, AND REQUIRE A FINAL WRITTEN REPORTING AND ACCOUNTING FOR HOW THE GRANT FUNDS WERE SPENT. GATES PHILANTHOPY PARTNERS HAS THE AUTHORITY TO WITHHOLD AND/OR RECOVER ANY GRANT FUNDS THAT ARE, OR APPEAR TO BE, MISUSED. FROM TIME TO TIME, SPOT AUDITS ARE CONDUCTED ON SELECTED GRANTEES TO MONITOR WHETHER THE GRANTEES ARE COMPLYING WITH THE TERMS OF THEIR GRANT AGREEMENTS. ADDITIONALLY, OUTSIDE EXPERTS ARE PERIODICALLY ENGAGED TO PERFORM EVALUATION OF SELECTED GRANTEES TO ENSURE THE FUNDS ARE BEING USED FOR THE PURPOSES OF THE GRANT. 0 0 0 0 0 0 0 0 0 MARK SUZMAN DIRECTOR (END 8/12/2020) 0 1172685 0 4000 0 38390 0 42750 0 39173 0 1296998 0 0 CONNIE COLLINGSWORTH DIRECTOR & BOARD CHAIR 0 895125 0 3500 0 52275 0 42750 0 27832 0 1021482 0 0 ALLAN GOLSTON DIRECTOR (START 8/12/2020) 0 796867 0 3500 0 34830 0 42750 0 27832 0 905779 0 0 LISA JOHNSEN DIRECT. & SEC. (START 3/18/20) 0 409483 0 13632 0 26989 0 42750 0 26166 0 519020 0 0 ROBERT ROSEN EXECUTIVE DIRECTOR 0 347296 0 9000 0 3634 0 42750 0 37192 0 439872 0 0 JONATHAN CASTRODALE TREASURER (START 11/2/2020) 0 305875 0 4132 0 3385 0 42750 0 36930 0 393072 0 0 SUSAN DESMOND-HELLMANN DIRECTOR (END 1/31/2020) 0 218476 0 0 0 120882 0 34019 0 5632 0 379009 0 0 PART I, LINE 3 THE TOP MANAGEMENT OFFICIAL IS UNCOMPENSATED BY THE REPORTING ORGANIZATION. THE REPORTING ORGANIZATION RELIES ON BILL & MELINDA GATES FOUNDATION, ITS SOLE MEMBER, TO ESTABLISH COMPENSATION FOR THE TOP MANAGEMENT OFFICIAL. PART VII, SECTION A, LINE 1: THE OFFICERS OF THE ORGANIZATION WERE COMPENSATED BY BILL & MELINDA GATES FOUNDATION, THE SOLE MEMBER OF GATES PHILANTHROPY PARTNERS. SELECT OFFICERS WERE EMPLOYED BY BILL & MELINDA GATES FOUNDATION FOR THE ENTIRE 2020 TAX YEAR BUT WERE NOT OFFICERS AT GATES PHILANTHROPY PARTNERS FOR THE FULL CALENDAR YEAR. COMPENSATION OF THESE OFFICERS IS LISTED IN FULL AND HAS NOT BEEN REDUCED OR PRO-RATED DUE TO PARTIAL YEAR INVOLVEMENT WITH GATES PHILANTHROPY PARTNERS. FORM 990, PART VI, SECTION A, LINE 2 SUSAN DESMOND-HELLMANN, MARK SUZMAN, CONNIE COLLINGSWORTH, GREG FERRANTE, ROBERT ROSEN, LISA JOHNSEN, ALLAN GOLSTON, AND JONATHAN CASTRODALE HAVE A BUSINESS RELATIONSHIP AS EMPLOYEES OF THE BILL & MELINDA GATES FOUNDATION. FORM 990, PART VI, SECTION A, LINE 6 THE SOLE MEMBER OF GATES PHILANTHROPY PARTNERS IS BILL & MELINDA GATES FOUNDATION. FORM 990, PART VI, SECTION A, LINE 7A BILL & MELINDA GATES FOUNDATION, THE SOLE MEMBER OF GATES PHILANTHROPY PARTNERS, HAS THE AUTHORITY TO APPOINT AND REMOVE DIRECTORS. FORM 990, PART VI, SECTION A, LINE 7B BILL & MELINDA GATES FOUNDATION, THE SOLE MEMBER OF GATES PHILANTHROPY PARTNERS, HAS THE AUTHORITY TO AMEND THE ARTICLES OF INCORPORATION, ADOPT A PLAN OF MERGER OR CONSOLIDATION, AUTHORIZE THE SALE, LEASE, OR EXCHANGE OF ALL OR SUBSTANTIALLY ALL OF THE ASSETS OF THE ORGANIZATION, AUTHORIZE THE VOLUNTARY DISSOLUTION OF THE ORGANIZATION AND ADOPTION OF A PLAN FOR THE DISTRIBUTION OF THE ASSETS OF THE ORGANIZATION. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS PREPARED BY A THIRD-PARTY ACCOUNTANT. AFTER PREPARATION, IT IS REVIEWED IN DETAIL BY THE TREASURER OF GATES PHILANTHROPY PARTNERS, AND THE TAX TEAM AND CONTROLLER OF BILL & MELINDA GATES FOUNDATION, THE SOLE MEMBER OF GATES PHILANTHROPY PARTNERS. A COPY OF THE FORM 990 IS PROVIDED TO THE ENTIRE BOARD OF GATES PHILANTHROPY PARTNERS PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C ALL OFFICERS, DIRECTORS AND KEY EMPLOYEES ARE CONSIDERED "COVERED PERSONS" FOR THE ORGANIZATION'S CONFLICT OF INTEREST POLICY, AND AS SUCH, ARE REQUIRED TO ANNUALLY DISCLOSE ANY RELATIONSHIPS THAT COULD GIVE RISE TO CONFLICTS OF INTEREST INVOLVING THE ORGANIZATION. IN ADDITION, ANY TRANSACTIONS BETWEEN THE ORGANIZATION AND ANY OF THESE INDIVIDUALS (OR THEIR FAMILY MEMBERS OR AN AFFILIATED ENTITY) MUST BE DISCLOSED TO THE SECRETARY. IF THE SECRETARY HAS A POTENTIAL CONFLICT OF INTEREST, IT MUST BE DISCLOSED TO THE EXECUTIVE DIRECTOR. THE SECRETARY AND EXECUTIVE DIRECTOR ARE RESPONSIBLE FOR REVIEWING THE ANNUAL CONFLICT OF INTEREST DISCLOSURES AND RESOLVING ANY POTENTIAL CONFLICT OF INTERESTS THAT MAY ARISE. THE COVERED PERSON IS REQUIRED TO REFRAIN FROM USING HIS OR HER PERSONAL INFLUENCE TO ENCOURAGE THE ORGANIZATION TO ENTER INTO THE COVERED TRANSACTION. ADDITIONALLY, HE OR SHE MUST NOT PARTICIPATE IN ANY DISCUSSIONS REGARDING THE COVERED TRANSACTIONS WITH OFFICERS, DIRECTORS AND EMPLOYEES OF THE ORGANIZATION, EXCEPT TO RESPOND TO REQUESTS FOR INFORMATION. IF THE TRANSACTION IS DEEMED TO BE REASONABLE BY THE DISINTERESTED DIRECTORS (IN THE CASE OF A CONFLICT INVOLVING A DIRECTOR OR THE EXECUTIVE DIRECTOR) OR EXECUTIVE DIRECTOR (IN THE CASE OF A CONFLICT INVOLVING ANOTHER OFFICER OR KEY EMPLOYEE), THE ORGANIZATION MAY ENTER INTO THE TRANSACTION, AS LONG AS IT IS FAIR AND REASONABLE TO THE ORGANIZATION. FORM 990, PART VI, SECTION B, LINE 15 GATES PHILANTHROPY PARTNERS DID NOT COMPENSATE ITS EXECUTIVE DIRECTOR OR OTHER OFFICERS. THE ORGANIZATION HAD NO EMPLOYEES AND THE OFFICERS WERE COMPENSATED BY BILL & MELINDA GATES FOUNDATION, THE SOLE MEMBER OF GATES PHILANTHROPY PARTNERS. BILL & MELINDA GATES FOUNDATION HAS A PROCESS TO DETERMINE COMPENSATION WHICH INCLUDES APPROVAL BY INDEPENDENT PERSONS, COMPARABILITY DATA, AND CONTEMPORANEOUS DOCUMENTATION. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST. GATES PHILANTHROPY PARTNERS' FINANCIAL STATEMENTS ARE CONSOLIDATED WITH BILL & MELINDA GATES FOUNDATION, AND THE CONSOLIDATED FINANCIAL STATEMENTS ARE AVAILABLE AT WWW.GATESFOUNDATION.ORG. FORM 990, PART IX, LINE 11G OTHER CONSULTING SERVICES: PROGRAM SERVICE EXPENSES 489,406. MANAGEMENT AND GENERAL EXPENSES 11,780. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 501,186. DONATION PROCESSING SERVICES: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 63,050. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 63,050. BILL & MELINDA GATES FOUNDATION (BMGF) PO BOX 23350 SEATTLE WA 98102 562618866 GRANTMAKING FOUNDATION WA 501(C)(3) PF N/A 0 BILL & MELINDA GATES MEDICAL RESEARCH INSTITUTE ONE KENDALL SQ BLDG 600 CAMBRIDGE MA 02139 821808476 MEDICAL RESEARCH WA 501(C)(3) LINE 4 BILL & MELINDA GATES FOUNDATION 1 BILL & MELINDA GATES FOUNDATION TRUST (BMGFT) PO BOX 23350 SEATTLE WA 98102 911663695 GRANTMAKING FOUNDATION WA 501(C)(3) PF N/A 0 ACCELERATOR GPS SIDE CAR FUND LP PO BOX 13329 RESEARCH TRIANGLE PARK NC 27709 814667411 PROGRAM RELATED INVESTMENT OF BMGF DE N/A 0 0 GREENBRIAR AS HOLDINGS LP 555 THEODORE FREMD AVE STE A-201 RYE NY 10580 981208908 INVESTMENT OF BMGFT CJ N/A 0 0 GREENBRIAR EQUITY FUND III AIV MM NV LP 555 THEODORE FREMD AVE STE A-201 RYE NY 10580 811112433 INVESTMENT OF BMGFT DE N/A 0 0 GREENBRIAR EQUITY FUND III AIV NV LP 555 THEODORE FREMD AVE STE A-201 RYE NY 10580 981208417 INVESTMENT OF BMGFT CJ N/A 0 0 GREENBRIAR EQUITY FUND III AIV SK NV LP 555 THEODORE FREMD AVE STE A-201 RYE NY 10580 473805287 INVESTMENT OF BMGFT DE N/A 0 0 GREENBRIAR EQUITY FUND III-A AIV WFCI LP 555 THEODORE FREMD AVE STE A-201 RYE NY 10580 981219020 INVESTMENT OF BMGFT CJ N/A 0 0 GREENBRIAR EQUITY FUND III-A LP 555 THEODORE FREMD AVE STE A-201 RYE NY 10580 461543216 INVESTMENT OF BMGFT DE N/A 0 0 THE GLOBAL GOOD FUND I LLC 3150 139TH AVE SE BELLEVUE WA 98005 272796838 INVESTMENT OF BMGFT DE N/A 0 0 AFRICAN AGRICULTURAL CAPITAL FUND LLC 6TH FLOOR TOWER A CYBERCITY EBENE MP 981017696 PROGRAM RELATED INVESTMENT OF BMGF MP N/A C 1 GREENBRIAR AS LP 555 THEODORE FREMD AVE STE A-201 RYE NY 10580 981208754 INVESTMENT OF BMGFT CJ N/A C 0 0 1 1 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 0 BILL & MELINDA GATES MEDICAL RESEARCH INSTITUTE B 18000000 CASH GRANT FOR COVID-19 RESPONSE